baber/WOPTO huggingface dataset:
Patent NZ-241815-A (NZ)
Title: Preparation of hydrocarbons by the pyrolysis of (olefin) polymer waste (or scrap) in the presence of a fluidising gas an a fluidised bed of inert particulate material
Inventor: KIRKWOOD KENNETH CLARK
IPC: C10G1/00
Filed: 1992-03-03
Abstract: This invention relates to a process for the conversion of waste and/or fresh polymers, especially polyolefins, into lower hydrocarbons by vaporising them in a fluidised bed of particulate material in the presence of a fluidising gas at a temperature from 300-690 DEG C. The lower hydrocarbons can be further converted to useful olefins, paraffins or waxes by steam cracking the lower hydrocarbons, preferably in the absence of any catalyst. This is an effective and efficient method of recycling waste polymers. <IMAGE>
Patent NZ-255666-A (NZ)
Title: Food/drink containers formed from a hydraulically settable binder, water and a rheology-modifying agent
Inventor: ANDERSEN PER JUST
IPC: B29C51/08
Filed: 1993-07-30
Abstract: Compositions and methods for manufacturing sheets having a hydraulically settable matrix. Suitable compositions are prepared by mixing together a hydraulic binder, water, and appropriate additives (such as aggregates, fibers, and rheology-modifying agents) which impart predetermined properties so that a sheet formed therefrom has the desired performance criteria. The compositions are formed into sheets by first extruding them into a sheet and then calendering the sheet using a set of rollers. The calendered sheets are dried in an accelerated manner to form a substantially hardened sheet. The drying is performed by heated rollers and/or a drying chamber. The hydraulically settable sheets so formed may have properties substantially similar to sheets made from presently used materials like paper, cardboard, polystyrene, or plastic. Such sheets can be rolled, pressed, scored, perforated, folded, and glued. They have especial utility in the mass production of containers, particularly food and beverage containers.
Patent NZ-276313-A (NZ)
Title: Sulphone-substituted polyethers and their use as conjugate carriers with bioactive materials
Inventor: HARRIS JOE MILTON
IPC: A61K47/48
Filed: 1994-11-14
Abstract: A poly(ethylene glycol) derivative is disclosed that is activated with a sulfone moiety for selective attachment to thiol moieties on molecules and surfaces. The activated PEG is water soluble, hydrolytically stable for extended periods, and forms hydrolytically stable linkages with thiol moieties. The linkages generally are not reversible in reducing environments. The PEG derivative is useful for modifying the characteristics of substances including modifying biologically active molecules and surfaces for biocompatibility. Methods for synthesizing the active PEG and for preparing conjugates of the active PEG and other substances, including biologically active substances, are also disclosed.
Patent NZ-287775-A (NZ)
Title: Process for removal of pox compounds, alendronate and alendronate byproducts after biphosphonate synthesis
Inventor: VENKATARAMANI EDAMANAL S
IPC: C02F1/52
Filed: 1995-06-02
Abstract: Disclosed is a process for removing by-product phosphorus-containing (POx) materials, alendronate and alendronate byproducts from crude mother liquors in an omega amino-1-hydroxy-C2-C6 alkylidene-1,1-bisphosphonic acid synthesis process, e.g. alendronate sodium. Calcium chloride is added first to the crude mother liquors, then calcium oxide to precipitate the POx materials, then neutralized to about pH 7 to complete precipitation. Substantially all of the alendronate sodium active ingredient is removed from the precipitate. Following filtration, the POx filtercake can then be disposed of by incineration, landfilling or reclamation of usable phosphorus as fertilizer. The remaining filtrate can then be further treated in an environmentally acceptable manner by wastewater treatment or recycling to the process.
Patent NZ-301194-A (NZ)
Title: Non-ionic, polymeric, absorbent foam and a flexible, microporous, open-celled material made from high internal phase emulsions; use in disposable diapers
Inventor: DESMARAIS THOMAS ALLEN
IPC: C08F2/32
Filed: 1996-01-11
Abstract: A polymeric foam material which is capable of acquiring and distributing aqueous fluids comprising a hydrophilic, flexible, nonionic polymeric foam structure of interconnected open cells is claimed having: a) a capacity after desorption at 30 cm of less than 10% of the foam's free absorbent capacity; b) a capillary absorption pressure of 3 to 20 cm; c) a capillary desorption pressure of 8  to 25 cm; d) a resistance to compression deflection of 5 to 85%^ when measured under a confirming pressure of 0.74 psi and e) a free absorbent capacity of 12 to 125 g/g.
Patent NZ-329763-A (NZ)
Title: Parenteral fluid delivery bag with integral line set
Inventor: BUTTITTA ANTHONY D
IPC: A61J1/05
Filed: 1997-04-17
Abstract: A parenteral fluid delivery bag having a line set formed integral with the bag, the line set being peelably releasable from the remainder of the bag so as to assume a deployed position adapted to enter into fluid communication with a patient. In an alternate embodiment, a plurality of bags connected by an integrally formed wye-junction are adapted for delivery to a patient and retrieval of fluid from a patient.
Patent NZ-500040-A (NZ)
Title: Coupling for attachment to fluid delivery pipe, includes actuator for valve in delivery pipe and quick release
Inventor: MCCRACKEN ROD
IPC: F16K15/18
Filed: 1999-09-30
Abstract: A removable outlet for tapping an outlet pipe (11) of an irrigation pipe includes housing (13) with axially movable spindle (29).  The housing fits onto the top of the irrigation pipe outlet.  Once fitted, rotation of handle (25) causes spindle (29) to move downwards and force valve (45) off its seat, so that water can flow from the irrigation pipe, and out through outlet pipe (16).  When the housing (13) is removed, valve (45) is closed by water pressure.  The lower part of the housing fits into the top of pipe (11) to form a fluid tight seal, and a flange (16) on the housing is locked to a flange (17) at the top of the irrigation pipe (11) in a plurality of different orientations.
Patent NZ-502965-A (NZ)
Title: Benzenesulfonamide inhibitors of phosphodiesterase-IV for treating inflammation and TNF associated diseases
Inventor: CONNOR DAVID THOMAS
IPC: A61P25/28
Filed: 1998-11-04
Abstract: A method of inhibiting PDE-IV or TNF comprising contacting a cell with a compound of the formula shown. The pharmaceutical composition is suitable for the treatment of inflammatory or autoimmune diseases. Wherein; R1 and R2 represents C1-4alkyl or C3-10cycloalkyl; R3 and R4 independently represents C1-4alkyl, cycloalkyl, C2-4alkylenes having one double bond, (CH2)nCO(CH2)mCH3, (CH2)pCN, (CH2)pCO2Me, or taken together with nitrogen atom to which they are attached, form a 3-to 10-membered ring; n and m are 0-3; p is 1 to 3.
Patent NZ-503484-A (NZ)
Title: Optionally benzo fused thieno[2,3-b]benzoxazepine, thieno[2,3-b]benzodiazepine or thieno[2,3-b]benzothiaxazepine derivatives
Inventor: TANAKA HIROSHI
IPC: C07D/
Filed: 1998-08-31
Abstract: A condensed thiophene compound of formula I is disclosed wherein: Ra and Rb are the same or different and are selected from hydrogen, alkyl, cycloalkyl, acyl, alkenyl, aryl, heteroaryl, aralkyl, hydroxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl, alkoxyalkyl, acyloxyalkyl, acylaminoalkyl, halogen, alkyl halide, or nitro, or Ra and Rb in conjunction may form a benzene or cyclohexane ring optionally having substituents R1 and R2, wherein R1 and R2 are the same or different and selected from hydrogen, alkyl, alkoxy, hydroxyl or halogen, X is selected from NH, O, S, SO, SO2 or N-R4 wherein R4 is alkyl, provided that when X is NH, Ra and Rb in conjunction form a benzene ring optionally having substituents R1 and R2 and when X is S, SO, or SO2, Ra and Rb in conjunction form a benzene or cyclohexane ring optionally having substituents R1 and R2. Ring A is a benzene ring optionally having 1-4 substituents that may be the same or different selected from alkyl, cycloalkyl, alkoxy, alkoxyalkyl, halogen, alkyl halide, nitro, amino, monoalkylamino, dialkylamino, acylamino, hydroxyl, or cyano, and R3 is selected from the group consisting of formulas (1), (2), (3), (26), (27), (28), (29), or (30), wherein: R5, R6 and R7 are the same or different and are selected from hydrogen, alkyl, cycloalkyl, aryl, heteroaryl, aralkyl, hydroxyalkyl, hydroxyalkoxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl, alkoxyalkyl, a is an integer of 2-4, R8 is selected from hydrogen, alkyl, cycloalkyl, aryl, heteroaryl aralkyl, hydroxyalkyl, hydroxyalkoxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl acyl, alkoxycarbonyl, or alkoxyalkyl, provided that when X is O, R8 cannot be aralkyl or if R8 is alkyl, hydroxyalkyl or alkoxyalkyl, the alkyl must have 1 to 4 carbons. b is an integer of 1 or 2, R9 is selected from hydrogen, alkyl, cycloalkyl, aryl, heteroaryl aralkyl, hydroxyalkyl, hydroxyalkoxyalkyl, aminoalkyl, monoalkylaminoalkyl, dialkylaminoalkyl acyl, alkoxycarbonyl, or alkoxyalkyl. These compounds are useful in the treatment of schizophrenia, Alzheimer's disease, manic-depressive illness and the like. Pharmaceutical agents and compositions involving such compounds are also disclosed.
Patent NZ-508354-A (NZ)
Title: Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth
Inventor: YOUNG AIPING H
IPC: A61K31/711
Filed: 1999-04-23
Abstract: Antisense oligonucleotide of less than 100 nucleotides comprising a sequence of at least 7 contiguous nucleotides of any one of SEQ ID NOs: 1-30, which inhibit neurophilin expression, are described. Pharmaceutical composition can contain the oligonucleotide or a vector comprising the oligonucleotide and are useful for inhibiting the growth and metastasis of tumor cells, for inhibiting neovascularization and for treating cancer. In vitro methods and methods of treating non-human animals comprising administrating the oligonucleotide are also described.
Patent NZ-520754-A (NZ)
Title: Identifying compounds that disrupt formation of critical gp41 six-helix bundle and conformations necessary for HIV entry thereby blocking virus entry to the cell
Inventor: WILD CARL T
IPC: G01N33/53
Filed: 2001-02-09
Abstract: Described are methods for identifying compounds that inhibit or prevent infection of cells by enveloped viruses such as HIV-1 by preventing or disrupting conformational changes in the viral transmembrane protein that are required for virus fusion with those cells, and the compounds discovered by such methods. These methods are also used as diagnostic assays to detect antibodies in virus infected individuals that inhibit the viral entry processes.
Patent NZ-527123-A (NZ)
Title: Oxazolyl-pyrazole derivatives as kinase inhibitors
Inventor: BERTA DANIELA
IPC: A61P17/06
Filed: 2002-01-28
Abstract: A compound which is an oxazolyl-pyrazole derivative represented by formula (I) and a process for preparing this compound is disclosed. The use of this compound represented by formula (I), in the preparation of a medicament for the treatment of a disease caused by and/or associated with an altered protein kinase activity is also disclosed. The disease caused by and/or associated with an altered protein kinase activity is selected from the group consisting of cancer, cell proliferative diseases, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative diseases.
Patent NZ-527441-A (NZ)
Title: Power unit with reciprocating linear movement based on stirling motor, and method used in said power plant
Inventor: FRANCOIS PIERRE
IPC: F02G1/043
Filed: 2002-01-17
Abstract: The generator has a working chamber (9) containing a piston (1), two displacers (2,3) and a fluid such as helium. The displacers are linked by a rod which passes through the piston and directed by control windings (5). Heat is applied (10) to the extremities of the working chamber which is cooled centrally by radiators (7). The piston constitutes the generator rotor and electrical power is generated in stator windings (6) Independent claims are made for methods used to generate electricity
Patent NZ-527969-A (NZ)
Title: A portable device for the enhancement of circulation and for the prevention of stasis related DVT
Inventor: WEINTRAUB DAVID
IPC: A61H7/00
Filed: 2002-03-03
Abstract: The present invention provides a portable device and method for enhancing blood flow in a limb and for reducing the risk of Deep Vein Thrombosis (DVT) formation by applying periodic squeezing forces on a limb, in particular a lower limb. The device comprises a flask-like casing box and a strap connected to opposite sides of the casing so as to form a closed loop around the limb. The box contains machinery for actuating periodical changes in the circumference of the closed loop between contracted and relaxed positions.
Patent NZ-531879-A (NZ)
Title: Dual action antibiotics
Inventor: HUBSCHWERLEN CHRISTIAN
IPC: A61K31/496
Filed: 2002-10-04
Abstract: Disclosed are chemically linked quinolone and oxazolidinone compounds of formula (I); pharmaceutical compositions containing the compounds; and the use of the compounds for the manufacture of medicaments for the treatment of bacterial infections, particularly against a variety of multi-drug resistant bacteria.
Patent NZ-531976-A (NZ)
Title: Method, device and computer program product for demultiplexing of video images
Inventor: GRINDSTAFF GENE ARTHUR
IPC: G06V10/20
Filed: 2002-09-06
Abstract: A method for demultiplexing digital video data which originates from multiple sources is disclosed. The method inlcludes: (a) Retrieving a first set of digital video data that is representative of a first image; (b) Storing the first set of digital video data to a memory location that is associated with a first source, such that the first set of digital video data is representative digital video data of the first source; (c) Retrieving a current set of digital video data that is representative of a current image, (d) Calculating a difference ratio using the representative digital video data and the current set of digital video data, and (e) If the difference ratio is above a threshold, producing a display query requiring a response for classifying the current digital video data as belonging to an identified source or originating from a new source, wherein the first source is an identified source.
Patent NZ-532728-A (NZ)
Title: Improved sill flashing
Inventor: HOTTON STEPHEN JOHN
IPC: E06B7/16
Filed: 2004-05-04
Abstract: A sill flashing (14) adapted to be mounted below and parallel to the lower edge of a window frame (4). The sill flashing comprising a first portion (15) adapted to lie behind the lower edge of window frame, a second portion (16) adapted to lie between the cladding and the framing beneath the lower edge of the window frame, a third portion (18) designed to provide an outwardly inclined cover for the top edge and a fourth portion (24) adapted to anchor the lower edge (23) of the third portion.
Patent NZ-533003-A (NZ)
Title: Doubly prestressed roof-ceiling construction with grid flat-soffit for extremely large spans
Inventor: SKENDZIC MILOVAN
IPC: E04B5/00
Filed: 2002-11-20
Abstract: A doubly prestressed roof-ceiling construction with grid flat-soffit for extremely large spans. The construction comprises a grid soffit construction (1) and an upper concrete girder (2) of a modified "T" shaped or of an inverse "V" shaped cross section, interconnected by slender steel pipe-rods (3) that stabilize the upper girder against lateral buckling. The empty openings within elements of the horizontal grid (1) are fulfilled with plates (6) wherewith a flat soffit is achieved. The construction is prestressed by double prestressing. The grid-soffit is prestressed centrically and the upper girder is prestressed by the wedge (5) at the midspan.
Patent NZ-538394-A (NZ)
Title: Vaccine for respiratory and reproductive system infections in cattles
Inventor: DOMINOWSKI PAUL JOSEPH
IPC: A61K39/02
Filed: 2003-08-14
Abstract: Disclosed is a immunogenic composition comprising: - a modified live Bovine Herpes Virus (BHV-1); - a modified live parainfluenza virus type 3 (PI3); - a modified live Bovine Respiratory Syncytial Virus (BRSV); - a Bovine Viral Diarrhea Virus Type-1 (BVDV-1); - a Bovine Viral Diarrhea Virus Type-2 (BVDV-2); and a veterinary-acceptable carrier.The composition can be used in inducing an immune response.
Patent NZ-538646-A (NZ)
Title: A synthetic heparin-binding growth factor analog
Inventor: PENA LOUIS A
IPC: A61K38/00
Filed: 2003-08-20
Abstract: Disclosed is synthetic heparin-binding growth factor analogs having at least one peptide chain, and preferably two peptide chains branched from a dipeptide branch moiety composed of two trifunctional amino acid residues, which peptide chain or chains bind a heparin-binding growth factor receptor and are covalently bound to a non-signaling peptide that includes a heparin-binding domain, preferably by a linker, which may be a hydrophobic linker. The synthetic heparin-binding growth factor analogs are useful as pharmaceutical agents, soluble biologics or as surface coatings for medical devices.
Patent NZ-539548-A (NZ)
Title: Gas valve with proportional output
Inventor: POWELL SIMON
IPC: F16K31/00
Filed: 2003-10-06
Abstract: A valve for controlling fluid flow comprising a body (100) provided with a fluid passageway having an inlet (10) and an outlet (90), a valve member for inhibiting fluid flow through the passageway, and means for moving the valve member (40, 50) so as to provide for controlled flow of fluid from the inlet to the outlet, wherein the valve member is in the form of a blade, one end of which is mounted at a location (41, 51) remote from the passageway; and wherein the means (60) of moving the valve member is arranged to act on the other end of the blade whereby to control fluid flow through the passageway.
Patent NZ-540217-A (NZ)
Title: Oxygen detection system for a rigid container
Inventor: BARMORE CHARLES R
IPC: B32B27/08
Filed: 2003-12-08
Abstract: Disclosed is a rigid container comprising a wall, the wall comprising: a) a first layer comprising an oxygen barrier having an oxygen transmission rate of no more than 100 cc/m2/24hr at 25 deg C, 0% RH, 1 atm (ASTM D 3985); and b) a second layer comprising an oxygen scavenger and a third layer comprising an oxygen indicator comprising a luminescent compound; or c) a second layer comprising an oxygen indicator comprising a luminescent compound and a third layer comprising an oxygen scavenger; wherein the oxygen indicator is substantially shielded by oxygen barrier layers from oxygen in the environment surrounding the container, and from oxygen in any headspace within the container; and wherein the oxygen indicator comprises all or part of a printed image. Also disclosed is a rigid container comprising: a) a tray comprising a tray flange, wherein the tray comprises an oxygen indicator comprising a luminescent compound; and b) a lidstock comprising an oxygen barrier having an oxygen transmission rate of no more than 100 cc/m2/24hr at 25 deg C, 0% RH, 1 atm (ASTM D 3985); and an oxygen scavenger. Also disclosed is a rigid container comprising: a) a tray comprising a tray liner, and a tray flange, wherein the tray liner comprises an oxygen indicator comprising a luminescent compound, and an oxygen scavenger; and b) a lidstock comprising an oxygen barrier having an oxygen transmission rate of no more than 100 cc/m2/24hr at 25 deg C, 0% RH, 1 atm (ASTM D 3985). Also disclosed is a rigid container comprising: a) a tray comprising a tray liner, and a tray flange, wherein the tray liner comprises an oxygen scavenger; and b) a patch, adhered to the tray flange, comprising an oxygen indicator comprising a luminescent compound, wherein the patch comprises an oxygen barrier having an oxygen transmission rate of no more than 100 cc/m2/24hr at 25 deg C, 0% RH, 1 atm (ASTM D 3985).
Patent NZ-541740-A (NZ)
Title: Risk management
Inventor: TSALAKOPOULOS CHRIS
IPC: G06Q10/06
Filed: 2004-02-19
Abstract: A risk management process for identification and tracking of a plurality of risks is disclosed. The process comprises step 1: defining a risk by providing a descriptive title; a risk impact value; and a likelihood value. Step 2 comprises setting the descriptive title, risk impact value and likelihood value as a first set of initial conditions for the risk. Step 3 comprises establishing a node for the risk with the first set of initial conditions associated therewith. Step 4 comprises repeating steps 1 and 2 on a possible further risk. Step 5 comprises determining if the initial conditions obtained in step 4 are identical with the initial conditions of the node established in step 3. If the initial conditions are not identical the descriptive titles are compared. If the descriptive titles are not identical, a further node is established with initial conditions determined at step 2 for that possible further risk or if the descriptive titles are identical, comparing both the impact values and the likelihood values. If one of those impact or likelihood values is identical the initial conditions of that possible further risk are associated with the risk node established at step 3 as a further initial condition and if neither of the impact or likelihood values is identical establishing an additional risk node with the initial conditions for that risk as determined in step 2 for that possible risk. The established nodes permit identification of the risks, and the subsequent tracking of the risks.
Patent NZ-542885-A (NZ)
Title: System for the projection of cinematographic works or digitial works with sound
Inventor: VINCENT PIERRE
IPC: H04R7/04
Filed: 2004-04-09
Abstract: A system for the projection of cinematographic or digital works with sound is provided. The system includes at least one sound channel and also includes a screen. The sound channel also includes at least one woofer and at least one medium/ treble speaker, where the screen is a non-perforated screen, the medium/treble speaker is a flat sound transducer placed against the screen at the rear and an extreme treble speaker is disposed on the periphery of the screen.
Patent NZ-544615-A (NZ)
Title: Dual drug dosage forms with improved separation of drugs
Inventor: LIM JONG
IPC: A61K9/22
Filed: 2004-07-13
Abstract: Disclosed is a method for the manufacture of a pharmaceutical tablet which upon oral ingestion delivers a first drug by immediate release and a second drug by prolonged release defined as a release rate into gastrointestinal fluid that is slow enough to leave at least about 40% of said second drug unreleased one hour after ingestion, said method comprising: a) dispersing said second drug in a solid matrix to form a unitary body which upon immersion in gastrointestinal fluid releases said second drug by prolonged release; b) depositing on a surface said unitary body a polymeric film that is devoid of either said first drug or said second drug; c) depositing over said polymeric film a fluid medium comprising said first drug and a liquid carrier that does not remove said polymeric film upon contact therewith; and d) evaporating said liquid carrier from said fluid medium thus deposited to leave a solid layer containing said first drug over said unitary body.